Table 25 Actual vs predicted molar refractivity of selected drugs.
Drug | Actual Molar Refractivity | Predicted Molar Refractivity |
|---|---|---|
Lenalidomide | 66.5 | 69.3476181 |
Thalidomide | 65.2 | 69.05353546 |
Cabozantinib | 137 | 141.53862 |
Sorafenib | 113.1 | 113.3841553 |
Sunitinib | 112.5 | 107.9411163 |
Axitinib | 113.5 | 109.1517792 |
Lenvatinib | 112 | 110.9681778 |
Erlotinib | 101.1 | 110.184494 |
Neratinib | 155.1 | 147.062027 |
Ifosfamide | 58.1 | 52.31801224 |
Cytarabine | 52.6 | 60.83347321 |
Docetaxel | 205.2 | 201.1650848 |
Paclitaxel | 219.3 | 218.0882263 |
Valrubicin | 169.8 | 179.3048401 |
Mitomycin C | 80.8 | 77.46327972 |
Erdafitinib | 129.6 | 128.6354218 |
Gemcitabine | 52.1 | 60.55062485 |
